In The Spotlight
- 20 June 2017 - 22 June 2017
- Shanghai, China
- 07 November 2020 - 10 November 2017
- Shanghai New International Exhibition Centre (SNIEC)
- Shanghai ,China
- 12 September 2017 - 14 September 2017
- Malmömassan – Malmö Convention Center Mässgatan 6 215 32
- Malmö – Sweden
- 05 May 2017 - 07 May 2017
- Bologna Fair Centre
- Bologna, Italy
- 15 May 2017 - 18 May 2017
- National Exhibition and Convention Center
- Shanghai, China
Beactica AB, the Swedish drug discovery company announced a new research collaboration with Uppsala University and the Drug Discovery and Development Platform at SciLifeLab to study the effects on brain cancer stem cells of specific small molecules under development by Beactica.
InMed Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies announced the filing of a provisional patent application in the United States.
Aptar Pharma and Kali Care have announced that they entered into a partnership in order to address the challenge of monitoring adherence in ophthalmic clinical trials.
AstraZeneca and MedImmune, its global biologics research and development arm announced positive results for the Phase III PACIFIC trial, a randomised.
Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) manufacture at its facility in Research Triangle Park, North Carolina, USA.
MGC Diagnostics Corporation , a global medical technology company, today announced a new clinical study collaboration with Restech Srl to evaluate the diagnostic accuracy of the forced oscillation technique (“FOT”) to detect lung function abnormalities.
Sartorius Stedim Biotech (SSB), a leading international supplier to the biopharmaceutical industry announced an agreement with Nova Biomedical (Nova), a well-known US manufacturer of cell culture analyzers, to integrate their BioProfile® FLEX2 into the ambr® multi-parallel bioreactor systems for automated, at-line cell culture analytics.
Contract development and manufacturing organisation (CDMO) Saneca Pharma has been granted a multiple dosage form approval for the manufacture and supply of solids, semi-solids and liquid finish dose products to Russia.
At interpack 2017, Bosch Packaging Technology shows how industry 4.0 solutions provide higher efficiency in modern manufacturing. “All of our industry 4.0 applications focus on humans,” says Dr Stefan König, president of Bosch Packaging Technology.
New industry research reveals that more than one third (36 per cent) of pharmaceutical manufacturers and contract packagers are not currently preparing for global serialization requirements, despite impending deadlines.
Bosch Packaging Technology generated sales of 1.3 billion euros in the 2016 fiscal year, similar to the previous year.As in years past, the leading provider of process and packaging technology, headquartered in Waiblingen near Stuttgart, Germany, split its sales more or less equally between its pharmaceutical and food business.
At interpack 2017, Bosch Packaging Technology shows how Industry 4.0 solutions help to achieve higher process safety and product quality.
Clinical research generates extensive amounts of data, yet most of it is siloed or generally unavailable to a larger pool of willing potential researchers. If this data were liberated to the masses, we would venture into a world of endless possibilities where the search for new cures and treatments could be accelerated.
TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced financial and company results for the first quarter of 2017.
A global life science technology firm has surpassed the €20 million milestone for sales of its manufacturing execution system (MES) services.
Imprimis Pharmaceuticals Inc , an ophthalmology-focused pharmaceutical company, announced that it has entered into an licensing agreement for the exclusive worldwide rights to Klarity, an innovative and patented ophthalmic topical solution and gel technology for patients with dry eye disease (DED).
At the discovery and early stages of drug development, the aim is to evaluate the pharmacology, pharmacokinetics and toxicology of a compound using a simple liquid formulation.
The last decade has seen an increased emphasis on research and development into personalized medicines, including cell, gene and immunotherapy treatments
Today, the chief purpose of primary packaging is product protection. However this performance capability has become more challenging in recent years as the complexity of active pharmaceuticals and their supply chain increases.
The eighth HKTDC Hong Kong International Medical Devices and Supplies Fair opened today at the Hong Kong Convention and Exhibition Centre (HKCEC).
Agenus Inc , an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies and cancer vaccines, today announced that the first patient has been dosed in a Phase 1/2 clinical trial of its anti-PD-1 antibody, AGEN2034.
This year’s edition of MEDICAL FAIR THAILAND is set to be its biggest yet with more than 700 international exhibitors expected. 17 national and country pavilions will present more than 5,000 state-of-the-art medical and healthcare products, equipment and solutions to a targeted audience of 10,000 medical and healthcare professionals.